Skip to main content
. 2019 May 29;8:212581. doi: 10.7573/dic.212581

Table 2.

Proportion of patients who achieved target serum uric acid levels (<6 mg/dL) with lesinurad in combination with allopurinol. Pooled data from CLEAR 1 and CLEAR 2. Reproduced from Zurampic et al.17

Timepoint Placebo + allopurinol N=407 Lesinurad 200 mg + allopurinol N=405 Lesinurad 200 mg versus placebo
Months 4, 5, 6 48 (12%) 155 (38%) 0.26 (0.21, 0.32)
Month 6 104 (26%) 222 (55%) 0.29 (0.23, 0.36)
Month 12 105 (26%) 203 (50%) 0.24 (0.18, 0.31)